Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
CytoDyn Inc
CYDY
Healthcare
Biotechnology
CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells. The Company is studying leronlimab in multiple therapeutic areas, including...
infectious disease, cancer, and autoimmune conditions. Its core areas of clinical development are human immunodeficiency viruses (HIV), non-alcoholic steatohepatitis (NASH), and solid tumors in oncology. The areas of clinical focus in HIV are the lifting of the clinical hold, creation of a long-acting formulation of leronlimab and an HIV functional cure in using adenovirus vectors (AAV). In NASH, its focus is on the general population of those affected by NASH, and the subpopulation of patients with NASH and HIV. Regarding oncology, its focus remains on combination therapy for solid tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:CYDY)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(2)
•••
tikotiko
X
View Profile
View Bullboard History
Post by
tikotiko
on Jun 21, 2020 6:42pm
Ready for takeoff
CYDY's share price increased by over 20% this week. If the company shows good test results next month and gets FDA approvalsoon, it will easily get to at least $5 or much higher. I
...more
(2)
•••
flashme1
X
View Profile
View Bullboard History
Post by
flashme1
on Jun 14, 2020 9:56pm
you all die off with covid-19
pretty quiet out there wheres all the chatter bugs now not the time to give up on cydy now only up from here
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 25, 2020 10:13am
Comparison David (Cytodyn) against Goliath (Gilead):
https://investorshangout.com/post/view?id=5777103
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 25, 2020 10:13am
San Francisco Chronicle:
Bay Area search for coronavirus drugs extends far beyond remdesivir By J.D. Morris 2 hrs ago https://www.msn.com/en-us/Health/medical/bay-area-search-for-coronavirus-drugs-extends-far-beyond
...more
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 23, 2020 1:09am
CytoDyn to Hold Conference Call to Provide Updates on COVID
CytoDyn to Hold Conference Call to Provide Updates on COVID-19 (Phase 2, 3 & eIND), Cancer (mTNBC, Phase 2 for 22 Solid Tumor Cancers), HIV (BLA, Monotherapy), NASH, GvHD and MS May 22
...more
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 22, 2020 3:41pm
COVID-19 Insights: Leronlimab (Youtube Dr. Been)
Drbeen Medical Lectures 163.000 Follower COVID-19 Insights: Leronlimab A good comprehensive article https://www.genengnews.com/covid-19-candidates/cytodyn/ A study on COVID
...more
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 22, 2020 2:46pm
Dr. B. Patterson Presentation at Beckman Coulter with Notes:
Dr. Bruce Patterson thanks Beckman Coulter for the invitation. He wants to talk about Rantes/CCL5. These are levels we've never seen before in Covid patients. How do these immune cells get to
...more
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 16, 2020 5:03pm
COVID-19 Research Symposium vom May 19-21 with Dr. Patterson
Bruce Patterson, M.D. Disruption of the CCL5/RANTES-CCR5 Pathway 1 Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19 CEO, IncellDx, California, USA 12:00 - 12:30 pm
...more
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 16, 2020 4:41pm
COVID-19 and Cancer: a Comprehensive Review
Not sure this was posted it mentions Leronlimab. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206576/
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 15, 2020 7:15am
News:CytoDyn to Offer No-Cost Exploratory Laboratory Testing
https://www.cytodyn.com/newsroom/press-releases/detail/431/cytodyn-to-offer-no-cost-exploratory-laboratory-testing-for CytoDyn to Offer No-Cost Exploratory Laboratory Testing for Childhood
...more
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 14, 2020 1:08pm
Cytodyn named top 4 choices for a possible corona crisis win
Regeneron: Market capitalization $ 64 billion Gilead Sciences: Market capitalization $ 96.7 billion GlaxoSmithKline: Market capitalization $ 96.5 billion far behind (ironically meant
...more
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 14, 2020 6:03am
Wow - a must read!
Excerpt: Then there’s Samsung’s biopharmaceutical arm, Samsung Biologics. In the first quarter of this year, ending in March, sales for Samsung Electronics rose 5.6 percent year over year, while sales
...more
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 14, 2020 4:38am
Excellent! Leronlimab: The Ultimate Solution for Corona Viru
Excellent! Leronlimab: The Ultimate Solution for Corona Virus | Syska Series | Ep. 12 {^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/embed/IDSmPY7kCA4|(fs
...more
(1)
•••
sunny3999
X
View Profile
View Bullboard History
Post by
sunny3999
on May 14, 2020 3:47am
CytoDyn NEXT SUPER STOCK livestream 5/13/20. Leronlimab
CytoDyn (CYDY) NEXT SUPER STOCK livestream 5/13/20. Leronlimab COVID-19 treatment update. {^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com/watch?v=Dg-PCkcn0Bw|(fs)True
...more
(0)
•••
WallstreetPR
X
View Profile
View Bullboard History
Post by
WallstreetPR
on May 12, 2020 10:07am
The Coronavirus Coping Portfolio (QDEL, GILD, QBIO, CYDY)
The COVID-19 pandemic has forced a dramatic realignment of social, cultural, and economic agendas because, in all cases, the healthcare issue has priority. It’s not a genuine public debate – if you
...more
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market